
Sudheer M. Dhoop MD
Former Chief Resident, University of Toledo | Clinical Assistant Professor & Academic Hospitalist, University of Michigan
Join to View Full Profile
1500 E Medical Center DrAnn Arbor, MI 48109
Dr. Dhoop is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board certified internal medicine physician currently passionate about delivering high-quality care to hospitalized patients.
Education & Training
- University of ToledoChief Residency, Internal Medicine, 2024 - 2025
- University of ToledoResidency, Internal Medicine, 2021 - 2024
- Cleveland Clinic FoundationInternship, Internal Medicine, 2018 - 2019
- Wayne State University School of MedicineClass of 2018
Certifications & Licensure
- MI State Medical License 2025 - 2028
- OH State Medical License 2018 - 2027
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Empagliflozin-Induced Nondiabetic Ketoacidosis in Advanced Alcoholic Liver Disease.Sudheer Dhoop, Mohammed Shehada, Ahmad Abdelrahman, Abdel-Rhman Mohamed, Thomas Sodeman
ACG Case Reports Journal. 2025-08-01 - Sodium-Glucose Cotransporter-2 Inhibitors in Liver Cirrhosis: A Systematic Review of Their Role in Ascites Management, Slowing Disease Progression, and Safety.Sudheer Dhoop, Sami Ghazaleh, Luke Roberts, Mohammed Shehada, Manthanbhai Patel
International Journal of Molecular Sciences. 2025-05-16 - Social Determinants of Health Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence and Severity: A Systematic Review and Meta-Analysis.Mohammed Abu-Rumaileh, Sudheer Dhoop, Jordan Pace, Thabet Qapaja, Maria Elena Martinez
The American Journal of Gastroenterology. 2025-03-17
Abstracts/Posters
- Hepatic Steatosis is Associated With Amplified Hypoglycemia and Diabetic Ketoacidosis Risk in Type 2 Diabetes: A Multicenter Propensity-Matched StudyDhoop S., Abu-Rumaileh M., Pace J. Tincopa M., Hassan M., AJG Supplement/ACG 2025, Phoenix, 10/2025
- Efficacy and Safety of GLP-1 Receptor Agonists in Metabolic Associated Steatohepatitis With Significant Fibrosis or Cirrhosis: A Systematic Review and Meta-Analysis of...Dhoop S., Sawaf B. Arch A.J., Hassan M., AJG Supplement/ACG 2025, Phoenix, 10/2025
- Non-Diabetic Ketoacidosis Following Empagliflozin Initiation In A Patient With Alcohol Associated Liver Disease: A Cautionary TaleDhoop S., Rabeeah S., Sodeman T., AJG Supplement/ACG 2025, Phoenix, 10/2025
- Join now to see all
Committees
- Internal Medicine Chief Resident, General Medical Education Committee 2024 - 2025
- Student Representative/Voting Member, Medical School Curriculum Committee 2014 - 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: